Astanina, Elena http://orcid.org/0000-0003-1366-5258
Doronzo, Gabriella
Corà , Davide
Neri, Francesco
Oliviero, Salvatore http://orcid.org/0000-0002-3405-765X
Genova, Tullio http://orcid.org/0000-0001-7824-8389
Mussano, Federico http://orcid.org/0000-0001-5800-0749
Middonti, Emanuele
Vallariello, Edoardo
Cencioni, Chiara
Valdembri, Donatella http://orcid.org/0000-0003-4590-417X
Serini, Guido http://orcid.org/0000-0002-3502-8367
Limana, Federica
Foglio, Eleonora
Ballabio, Andrea http://orcid.org/0000-0003-1381-4604
Bussolino, Federico http://orcid.org/0000-0002-5348-1341
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (22910)
Regione Piemonte (grant A1907A, Deflect, A1907A, Deflect)
Fondazione CRT
Ministero dell'Istruzione, dell'Università e della Ricerca (PRIN 2017, grant 2017237P5X)
Article History
Received: 16 July 2021
Accepted: 17 August 2022
First Online: 3 September 2022
Competing interests
: A.B. is cofounder of Casma Therapeutics and advisory board member of Next Generation Diagnostics, Avilar Therapeutics and Coave Therapeutics. The other authors declare no competing interests.